Literature DB >> 21868519

In vitro and in vivo anticancer activity of (+)-spongistatin 1.

Qunli Xu1, Kuan-Chun Huang, Karen Tendyke, Joanne Marsh, Junke Liu, Dayong Qiu, Bruce A Littlefield, Kenichi Nomoto, Onur Atasoylu, Christina A Risatti, Jeffrey B Sperry, Amos B Smith.   

Abstract

The marine natural product (+)-spongistatin 1 is an extremely potent growth inhibitory agent having activity against a wide variety of cancer cell lines, while exhibiting low cytotoxicity against quiescent human fibroblasts. Consistent with a microtubule-targeting mechanism of action, (+)-spongistatin 1 causes mitotic arrest in DU145 human prostate cancer cells. More importantly, (+)-spongistatin 1 exhibits significant in vivo antitumor activity in the LOX-IMVI human melanoma xenograft model. (+)-Spongistatin 1 is, thus, an important class of microtubule targeting anticancer agent that warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868519      PMCID: PMC3181053     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1.

Authors:  Amos B Smith; Chris Sfouggatakis; Christina A Risatti; Jeffrey B Sperry; Wenyu Zhu; Victoria A Doughty; Takashi Tomioka; Dimitar B Gotchev; Clay S Bennett; Satoshi Sakamoto; Onur Atasoylu; Shohei Shirakami; David Bauer; Makoto Takeuchi; Jyunichi Koyanagi; Yasuharu Sakamoto
Journal:  Tetrahedron       Date:  2009-09-15       Impact factor: 2.457

2.  Design, synthesis, and biological evaluation of EF- and ABEF- analogues of (+)-spongistatin 1.

Authors:  Amos B Smith; Christina A Risatti; Onur Atasoylu; Clay S Bennett; Karen Tendyke; Qunli Xu
Journal:  Org Lett       Date:  2010-04-16       Impact factor: 6.005

3.  The solution structure of (+)-spongistatin 1 in DMSO.

Authors:  Onur Atasoylu; George Furst; Christina Risatti; Amos B Smith
Journal:  Org Lett       Date:  2010-04-16       Impact factor: 6.005

4.  Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned.

Authors:  Amos B Smith; Christina A Risatti; Onur Atasoylu; Clay S Bennett; Junke Liu; Hongsheng Cheng; Karen TenDyke; Qunli Xu
Journal:  J Am Chem Soc       Date:  2011-08-12       Impact factor: 15.419

5.  The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis.

Authors:  Andrea S Rothmeier; Uta M Schneiders; Romina M Wiedmann; Ivan Ischenko; Christiane J Bruns; Anita Rudy; Stefan Zahler; Angelika M Vollmar
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

Review 6.  Multiple drug resistance mechanisms in cancer.

Authors:  Bruce C Baguley
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

7.  Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.

Authors:  R Bai; Z A Cichacz; C L Herald; G R Pettit; E Hamel
Journal:  Mol Pharmacol       Date:  1993-10       Impact factor: 4.436

8.  Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates.

Authors:  Jiawang Liu; Guohui Cui; Ming Zhao; Chunying Cui; Jingfang Ju; Shiqi Peng
Journal:  Bioorg Med Chem       Date:  2007-09-01       Impact factor: 3.641

9.  Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP.

Authors:  L Schyschka; A Rudy; I Jeremias; N Barth; G R Pettit; A M Vollmar
Journal:  Leukemia       Date:  2008-06-12       Impact factor: 11.528

10.  The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.

Authors:  R Bai; G F Taylor; Z A Cichacz; C L Herald; J A Kepler; G R Pettit; E Hamel
Journal:  Biochemistry       Date:  1995-08-01       Impact factor: 3.162

View more
  9 in total

1.  Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking.

Authors:  Xingfeng Bao; Wanjun Zheng; Naoko Hata Sugi; Kishan L Agarwala; Qunli Xu; Zichun Wang; Karen Tendyke; Winnie Lee; Lana Parent; Wei Li; Hongsheng Cheng; Yongchun Shen; Noel Taylor; Zoltan Dezso; Hong Du; Yoshihiko Kotake; Nanding Zhao; John Wang; Maarten Postema; Mary Woodall-Jappe; Yasutaka Takase; Toshimitsu Uenaka; David G I Kingston; Kenichi Nomoto
Journal:  Cancer Biol Ther       Date:  2015-03-02       Impact factor: 4.742

Review 2.  Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways.

Authors:  Srimanta Patra; Prakash Priyadarshi Praharaj; Debasna Pritimanjari Panigrahi; Biswajit Panda; Chandra Sekhar Bhol; Kewal Kumar Mahapatra; Soumya Ranjan Mishra; Bishnu Prasad Behera; Mrutyunjay Jena; Gautam Sethi; Shankargouda Patil; Samir Kumar Patra; Sujit Kumar Bhutia
Journal:  Mol Biol Rep       Date:  2020-08-14       Impact factor: 2.316

3.  Structure and conformational analysis of spiroketals from 6-O-methyl-9(E)-hydroxyiminoerythronolide A.

Authors:  Ana Čikoš; Irena Ćaleta; Dinko Žiher; Mark B Vine; Ivaylo J Elenkov; Marko Dukši; Dubravka Gembarovski; Marina Ilijaš; Snježana Dragojević; Ivica Malnar; Sulejman Alihodžić
Journal:  Beilstein J Org Chem       Date:  2015-08-19       Impact factor: 2.883

Review 4.  Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies.

Authors:  Natalia Bailon-Moscoso; Gabriela Cevallos-Solorzano; Juan Carlos Romero-Benavides; Maria Isabel Ramirez Orellana
Journal:  Curr Genomics       Date:  2017-04       Impact factor: 2.236

Review 5.  Cytotoxic Compounds Derived from Marine Sponges. A Review (2010-2012).

Authors:  Roberto Mioso; Francisco J Toledo Marante; Ranilson de Souza Bezerra; Flávio Valadares Pereira Borges; Bárbara V de Oliveira Santos; Irma Herrera Bravo de Laguna
Journal:  Molecules       Date:  2017-01-28       Impact factor: 4.411

6.  Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1.

Authors:  Linda M Suen; Makeda A Tekle-Smith; Kevin S Williamson; Joshua R Infantine; Samuel K Reznik; Paul S Tanis; Tyler D Casselman; Dan L Sackett; James L Leighton
Journal:  Nat Commun       Date:  2018-11-09       Impact factor: 14.919

Review 7.  Peptides with Dual Antimicrobial-Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides.

Authors:  Yamil Liscano; Jose Oñate-Garzón; Jean Paul Delgado
Journal:  Molecules       Date:  2020-09-16       Impact factor: 4.411

Review 8.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

Review 9.  A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011.

Authors:  Wamtinga Richard Sawadogo; Marc Schumacher; Marie-Hélène Teiten; Claudia Cerella; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.